CATEGORY : Clinical Diagnostics

Life Science Market Reports

Our life science market intelligence products have been recognized by market insiders and outsiders alike for their accuracy, in-depth analysis, and unique insights.

Market Reports

Supplying the COVID Demand — How Dx Behemoths and Tele-Diagnostics Entrants Aim to Close the Gap

  As more COVID-19 diagnostics win FDA emergency use authorization, weekly commercial production capacity is expected to hit 6.5M+ tests; telehealth providers attempt to jump into the fray, but are

Digital Health Democratizes Precision Medicine to Improve Population Health

  By definition, precision medicine treats the individual while public health focuses on population-level interventions. While public health and precision medicine efforts overlap, some experts argue that precision medicine advancements

3 Takeaways for Digital Health from #CES2020

Consumer health techs hone clinical value propositions Criticism of the digital health space has largely centered on the lack of clinical utility and validity as a result of technologies built

3 Machine Learning / Artificial Intelligence Trends In The Diagnostics Space For 2020 And Beyond

2019 was another strong year for machine learning and artificial intelligence within the diagnostic space, and the acceleration of progress in ML / AI is clearly going to continue within

How Consumerization is Driving Evolution of Digital Health through Strategic Partnerships

Takeaways from HLTH 2019 Last week’s annual HLTH conference brought together 6,000 digital health leaders from every sector of the healthcare industry. Stakeholders from payor organizations, health systems, pharma, diagnostics

Pain Points, Unmet Needs, and Disruption in Precision Medicine – Part 1

DeciBio’s mission is to provide market intelligence and strategic insights that drive disruption and innovation in the precision medicine and life science industry. To this end, my colleague, Colin Enderlein,

Four Calls-to-Action for Digital Disrupters from #RHSUM19

Healthcare entrants, primarily startups and tech incumbents, came to the forefront of discussion at last week’s Rock Health Summit. As entrants emerge, healthcare is adapting to a proliferation of choice

Lessons Learned from the World’s First Gene-Edited Babies

Why enforceable regulation and greater inclusion and diversity in global discourse are critical to effective management of gene editing Earlier this week, He Jiankui, a professor at China’s Southern University

Three lessons for digital health entrepreneurs from #RHSUM18

This year’s Rock Health annual digital health summit showcased another impressive lineup, with speakers like Bernard Tyson (CEO of Kaiser Permanente), Toby Cosgrove (Executive Adviser for Google Cloud and former